Skip to main content
Quratis Inc. logo

Quratis Inc. — Investor Relations & Filings

Ticker · 348080 ISIN · KR7348080003 KO Manufacturing
Open in API
Filings indexed 238 across all filing types
Latest filing 2024-03-28 Regulatory Filings
Country KR South Korea
Listing KO 348080

About Quratis Inc.

https://www.quratis.com

Quratis Inc. is a biopharmaceutical company specializing in the research and development of vaccines and therapeutic agents for infectious diseases. The company's lead pipeline candidate is QTP101, a novel tuberculosis (TB) vaccine developed for adolescents and adults, an area with significant unmet medical needs. Quratis operates its own GMP-certified manufacturing facility, enabling the production of various biologics such as DNA plasmids, RNA, and proteins to support its development programs. The company is advancing the global commercialization of its TB vaccine through strategic partnerships and technology transfers, with notable progress in key Asian markets.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for a shareholder meeting (Extraordinary General Meeting). It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal notice of the record date for shareholder rights. Given the nature of the announcement regarding corporate governance and meeting preparation, it falls under the general regulatory filing category.
2024-03-28 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. This type of filing is a standard regulatory disclosure regarding insider shareholdings and transactions by directors or major shareholders. In the provided classification schema, 'Director's Dealing' (DIRS) is the most accurate category for reports detailing personal share transactions and ownership status by company directors and executives.
2024-03-27 Korean
전환사채(해외전환사채포함)발행후만기전사채취득 (제1회차)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from Quratis regarding the acquisition of convertible bonds before maturity (early redemption). It details the bond series, acquisition amount, reason (exercise of put option by bondholders), and future treatment (cancellation). This falls under capital structure changes and financing updates, specifically related to debt instruments.
2024-03-26 Korean
[기재정정]사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) filed by Quratis Inc. in South Korea. It contains comprehensive information including company overview, history, capital structure, management, and business operations for the fiscal year 2023. It is a formal, long-form annual filing submitted to the Financial Supervisory Service (FSS) and the Korea Exchange. According to the provided definitions, this corresponds to the '10-K' category, which covers official yearly reports of company activity and financial performance. FY 2023
2024-03-25 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled 'Audit Report Submission' (감사보고서 제출) submitted to the Korea Exchange (KRX). It provides the audit opinion (unqualified/proper), key financial data, and details regarding capital impairment and operating losses for the fiscal year. While it contains financial data, it is a standard regulatory disclosure form used in the Korean market to announce the receipt and filing of the audit report, rather than the full annual report document itself. Therefore, it is classified as a Regulatory Filing (RNS). FY 2023
2024-03-21 Korean
사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for the fiscal year 2023, covering company overview, history, capital structure, and detailed business operations. It is a formal, long-form regulatory filing submitted to the Financial Supervisory Service and the Korea Exchange. It contains substantive financial and operational data, fitting the definition of an Annual Report (10-K) in the context of Korean corporate filings. FY 2023
2024-03-21 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.